AL SB72

Prohibits the Alabama Board of Medical Examiners and Medical Licensure Commission of Alabama from revoking, suspending, failing to renew, or taking action against a physician's license based solely on prescribing or recommending off-label medical treatments.

Defines off-label medical treatment as the use of any drug, biological product, or device approved by the FDA in any manner other than the FDA-approved use.

Creates an exception allowing disciplinary action if the physician's off-label treatment presents a threat of significant harm to patients or the general public.

Excludes controlled substances from the protections, which remain subject to existing regulations under Alabama law.

Becomes effective October 1, 2024.